MARKER THERAPEUTICS (MRKR)
(Delayed Data from NSDQ)
$1.19 USD
-0.04 (-3.25%)
Updated Aug 8, 2025 04:00 PM ET
After-Market: $1.19 0.00 (0.00%) 7:58 PM ET
3-Hold of 5 3
F Value F Growth B Momentum F VGM
Fundamental Charts
About Market Cap
As of the previous market close, MARKER THERAPEUTICS, INC. has a market cap of $13.92M, which represents its share price of $1.23 multiplied by its outstanding shares number of 11.31M. As a small-cap company, MRKR's shareholders are generally exposed to more risk than shareholders of mid and large-cap companies.
The company's Market Capitalization is a measurement of company size. It is calculation of the company's share price times the number of outstanding shares. Large market cap companies give stability and are good long-term investments. Small market cap companies can produce faster growth and bigger returns, but their stockholders are exposed to more risk.
MRKR 1.19 -0.04(-3.25%)
Will MRKR be a Portfolio Killer in August?
Zacks Investment Research is releasing its prediction for MRKR based on the 1-3 month trading system that more than doubles the S&P 500.
Other News for MRKR
Marker Therapeutics to Participate in a Fireside Chat at the Canaccord Genuity 45th Annual ...
12 Health Care Stocks Moving In Thursday's Intraday Session
Dow Jumps Over 100 Points; PepsiCo Posts Upbeat Earnings
12 Health Care Stocks Moving In Thursday's Pre-Market Session
Strategic Collaborations and Promising Clinical Developments Drive Buy Rating for Marker Therapeutics